A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.
J Infect
; 85(2): 174-211, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35637031
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Klebsiella Infections
/
Carbapenem-Resistant Enterobacteriaceae
Limits:
Humans
Language:
En
Journal:
J Infect
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: